Meeting
2022 ASCO Quality Care Symposium
Uptake in genetic testing in patients with pancreatic cancer with oncologist-driven testing protocol.
Authors
Traci King
Beth Israel Deaconess Medical Center, Boston, MA
Traci King, Page Widick, Rodrigo Paredes, Oliver Klein, Jill Krejdovsky, Nadine M. Tung, Mary Linton Bounetheau Peters
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session A
Track
Cost, Value, and Policy,Health Care Access, Equity, and Disparities,Patient Experience
Sub Track
Guideline-Concordant Care Initiatives
Citation
J Clin Oncol 40, 2022 (suppl 28; abstr 33)
DOI
10.1200/JCO.2022.40.28_suppl.033
Abstract #
33
Poster Bd #
B3
Abstract Disclosures
Similar Posters
Poster
2022 ASCO Quality Care Symposium
Association of clinic type with receipt of neoadjuvant therapy among patients with localized pancreatic cancer: Value of multidisciplinary clinic.
First Author: Priya Pathak
Poster
2022 ASCO Quality Care Symposium
Single-center comparison of cancer genetics referral rates for patients with pancreatic cancer following implementation of a best practice advisory: A quality improvement project.
First Author: Stephanie Rivera Morales
Poster
2012 Gastrointestinal Cancers Symposium
Impact of a gastrointestinal multidisciplinary clinic on the quality of pancreatic cancer care delivery at a community cancer center.
First Author: Laurence E. McCahill
Poster
2024 ASCO Gastrointestinal Cancers Symposium
New cutoff of CA19-9 values for predicting pancreatic cancer using liquid biopsy.
First Author: Ryuji Hasebe